Sigue la actividad de operaciones con información privilegiada más reciente de NeuroPace. Mantente informado sobre las compras, ventas e impacto en el mercado recientes de las acciones de NeuroPace.
La actividad de uso de información privilegiada involucra a personas con información privilegiada de la empresa, como ejecutivos, directores y empleados, que participan en transacciones con acciones de su propia empresa. Las transacciones de compra y venta de los iniciados proporcionan información valiosa sobre su confianza en el desempeño futuro de la empresa.
Los expertos no han informado de compras ni ventas en los últimos 30 días.
No ha habido ninguna compra o venta de información privilegiada en los últimos 90 días.
May 16, 2025 | 10% OWNER | -168.14K | $15.85 | -$2.67M | SELL | -4.94% | 3.24M | May 14 | ||
Feb 25, 2025 | CHIEF MEDICAL OFFICER | -78.33K | $13.72 | -$1.07M | SELL | -48.86% | 81.99K | Feb 21 | ||
Feb 20, 2025 | 10% OWNER | -5.27M | $9.40 | -$49.55M | SELL | -100.00% | 0.00 | Feb 20 | ||
Jan 31, 2025 | CHIEF MEDICAL OFFICER | -300.00 | $15.00 | -$4.50K | SELL | -0.34% | 86.76K | Jan 29 - Jan 30 | ||
Jan 28, 2025 | CHIEF MEDICAL OFFICER | -3.20K | $15.01 | -$48.03K | SELL | -3.55% | 87.06K | Jan 24 | ||
Oct 28, 2024 | 10% OWNER | -224.14K | $5.45 | -$1.22M | SELL | -4.08% | 5.27M | Oct 23 - Oct 25 | ||
Oct 24, 2024 | 10% OWNER | -4.08K | $6.09 | -$24.85K | SELL | -0.07% | 5.49M | Oct 22 | ||
Oct 22, 2024 | 10% OWNER | -8.60K | $6.21 | -$53.37K | SELL | -0.16% | 5.50M | Oct 18 - Oct 21 | ||
Oct 18, 2024 | 10% OWNER | -46.43K | $6.53 | -$303.37K | SELL | -0.84% | 5.51M | Oct 03 - Oct 17 | ||
Oct 03, 2024 | 10% OWNER | -39.68K | $6.92 | -$274.71K | SELL | -0.71% | 5.55M | Aug 30 - Oct 02 | ||
May 03, 2024 | 10% OWNER | -29.21K | $14.02 | -$409.43K | SELL | -0.85% | 3.41M | May 01 - May 03 | ||
Apr 26, 2024 | 10% OWNER | -1.78K | $14.06 | -$25.04K | SELL | -0.05% | 3.44M | Apr 24 | ||
Apr 23, 2024 | 10% OWNER | -64.65K | $14.12 | -$913.06K | SELL | -1.85% | 3.44M | Apr 19 - Apr 23 | ||
Apr 18, 2024 | 10% OWNER | -16.99K | $14.02 | -$238.23K | SELL | -0.48% | 3.50M | Apr 16 - Apr 18 | ||
Apr 15, 2024 | 10% OWNER | -485.00K | $14.49 | -$7.03M | SELL | -12.11% | 3.52M | Apr 11 - Apr 12 | ||
Feb 06, 2024 | CHIEF MEDICAL OFFICER | -17.59K | $15.09 | -$265.40K | SELL | -18.45% | 77.76K | Feb 02 - Feb 05 | ||
Feb 01, 2024 | CHIEF MEDICAL OFFICER | -13.85K | $15.09 | -$208.97K | SELL | -12.68% | 95.35K | Jan 30 - Feb 01 | ||
Jan 26, 2024 | CHIEF MEDICAL OFFICER | -828.00 | $15.02 | -$12.44K | SELL | -0.75% | 109.20K | Jan 24 - Jan 25 | ||
Dec 28, 2023 | CHIEF MEDICAL OFFICER | -13.40K | $10.12 | -$135.67K | SELL | -10.86% | 110.03K | Dec 26 - Dec 27 | ||
Dec 22, 2023 | CHIEF MEDICAL OFFICER | -2.73K | $10.14 | -$27.70K | SELL | -2.16% | 123.43K | Dec 20 | ||
Dec 07, 2023 | CHIEF MEDICAL OFFICER | -11.01K | $8.16 | -$89.77K | SELL | -8.02% | 126.16K | Dec 06 | ||
Dec 01, 2023 | 10% OWNER | -16.17K | $8.78 | -$141.88K | SELL | -0.29% | 5.59M | Nov 29 - Dec 01 | ||
Nov 29, 2023 | — | -11.17K | $8.87 | -$99.11K | SELL | -0.20% | 5.61M | Nov 27 - Nov 28 | ||
Oct 04, 2023 | 10% OWNER | -8.31K | $9.07 | -$75.45K | SELL | -0.21% | 4.00M | Oct 02 - Oct 03 | ||
Nov 23, 2022 | 10% OWNER | 390.29K | $1.50 | $585.05K | BUY | 9.65% | 4.43M | Nov 21 - Nov 22 | ||
Jun 09, 2022 | GENERAL COUNSEL AND SECRETARY | -2.50K | $5.78 | -$14.44K | SELL | -3.93% | 61.14K | Jun 08 | ||
Mar 01, 2022 | GENERAL COUNSEL AND SECRETARY | -1.47K | $7.54 | -$11.08K | SELL | -18.10% | 6.65K | Feb 28 | ||
Apr 23, 2021 | 10% OWNER | 235.00K | $17.00 | $4.00M | BUY | ∞ | 235.00K | Apr 21 | ||
Apr 23, 2021 | GENERAL COUNSEL AND SECRETARY | 2.35K | $17.00 | $39.98K | BUY | ∞ | 2.35K | Apr 21 | ||
Apr 23, 2021 | 10% OWNER | 588.24K | $17.00 | $10.00M | BUY | ∞ | 588.24K | Apr 21 | ||
Apr 23, 2021 | DIRECTOR | 50.00K | $17.00 | $850.00K | BUY | 115.50% | 93.29K | Apr 21 | ||
Apr 23, 2021 | DIRECTOR | 13.23K | $17.00 | $225.00K | BUY | 51.66% | 38.85K | Apr 21 | ||
Apr 23, 2021 | DIRECTOR | 588.24K | $17.00 | $10.00M | BUY | ∞ | 588.24K | Apr 21 |
Explora operaciones con información privilegiada sobre todos los valores.